Company Snapshot
Genius Sports Limited · NYSE: GENI — technology, official sports data and sports media. The company connects leagues, betting operators and advertisers; shareholder value depends on converting growth into cash.
| Investment framework | Current view |
|---|---|
| Thesis status | Conditional growth thesis; Q3 strengthened the operating and cash-flow evidence. |
| Analytical confidence | Medium — rights, growth and the first positive operating profit are documented; sustainable full-year FCF, debt reduction and Legend's return still need confirmation. |
| Horizon | Three years and longer |
| Main test | Cash after software investment, interest, Legend-related payments and dilution. |
| Reference price | $5.92, November 5, 2026 closing price; NYSE ordinary share |
| Company strength | 6.6/10, assessed November 6, 2026; methodology 1.2 |
| Price attractiveness | 6.3/10 at $5.92, assessed November 6, 2026; methodology 1.2 |
| Next quarterly results | Date not yet researched because fewer than two months have elapsed since the latest results. |
| Evidence status | Partial coverage as of November 6, 2026; Q3 results and a public call transcript were included, but the Q3 transcript and presentation are not among the attached files. |
Amounts are in USD millions unless stated otherwise. Price history · Quote and statistics.
Investment Thesis
Update — November 6, 2026
Q3 revenue reached $269.9 million, adjusted EBITDA $87.1 million, operating income turned positive at $10.4 million and FCF reached $53.6 million. The thesis is stronger, but sustainable full-year FCF, debt reduction and Legend's return still need confirmation.
Genius can increase sports-data value through existing-customer spending, more products and media monetization. Exclusive rights, technology and league relationships create entry barriers. Success requires growing FCF per diluted share and lower debt. Results support growth; Legend returns and cash conversion remain conditions.
What matters most
- Sustainable growth: Q2 Betting +28%; further organic growth and customer monetization matter.
- Cash: H2 2026 bridge: 145 before interest − 30 interest − 10 principal ≈ 105 cash increase.
- Legend: owned audiences and ads must justify the acquisition despite search/AI changes.
- Per-share returns: rights renewals, debt, contingent payments and awards must not consume growth benefits.
The Business
Q3 update
GENI supplies official sports data and related technology to leagues, sportsbooks and media customers. Betting revenue grew 33.4% in Q3. Management said 70–80% of Betting revenue comes from fixed minimum guarantees and that major rights are secured through the end of the decade; these remain management statements subject to delivery and renewal economics.
Official data and technology for leagues, sportsbooks and media. Betting monetizes feeds/products; management says approximately 500 sportsbook brands. Media connects content, audiences and ad budgets. GeniusIQ supports collection, analytics, officiating, broadcast and the advertising Moment Engine. Q1 transcript · Q2.
Legend, consolidated from May 1, 2026, adds owned media and customer acquisition. The rationale is wider use of shared sports infrastructure, connecting official data, audiences and ads. Actual cash must establish synergies and returns.
Geography
| Customer-domicile region | Q2 revenue | Share |
|---|---|---|
| Europe | 93.7 | 47.9% |
| North/South America | 82.6 | 42.2% |
| Rest of world | 19.3 | 9.9% |
SEC Note 4. Calculated shares. Domicile is not betting location; the US alone was 27%. Americas is neither the US nor a direct Brazilian-exposure estimate.
Competitive Advantages
Company strength — updated November 6, 2026
6.6/10 under methodology 1.2. Competitive advantage 7.1, demand durability 8.1, management execution 7.3, business economics 5.5, financial resilience 5.2. The mean is 6.64, rounded to 6.6. Q3 added evidence on demand, execution, operating leverage and cash generation; the increase from 6.4 is unrelated to the share-price move. Q3 Betting grew 33.4%, adjusted EBITDA margin was 32.3%, operating income $10.4 million and FCF $53.6 million. Nine-month FCF remained negative $136.2 million, cash was $206.5 million and debt book value $787.4 million.
| Relationship | Verified scope and duration | Investment significance |
|---|---|---|
| NFL | Partnership for official data and related services through the end of the 2029 season, including Super Bowl 2030. | Access to valuable content and NFL ecosystem integration; licensing scope must be assessed for each specific use. |
| Football DataCo | Exclusive official live betting data for EPL, EFL and SPFL for 2025/26 through 2028/29, plus Player Market Data. | Strong UK football position and a foundation for more betting products. |
| Technology and customer relationships | GeniusIQ, low latency, distribution integrations and long-standing league/operator relationships. | A new competitor needs rights, infrastructure, trust and customer integration simultaneously. |
NFL · Football DataCo · Q2 transcript. My judgment: the moat is strong against a new startup but less certain against established competitors and leagues' bargaining power. Exclusivity has an expiry date and a price. The annual report states that NFL and UK football account for most third-party data fees and major rights are obtained through tenders. Leagues may therefore capture more of the value at renewal. 20-F, page 52.
AI has two sides — analytical judgment: it can lower collection costs and expand data usage, but a model cannot obtain an official stadium feed without a contract. For Legend's media, AI answers and search changes can simultaneously weaken traffic. Management's claim that owned audiences only benefit from AI should be tested against direct and returning traffic and actual revenue per visitor. Management arguments.
Business strength
Business strength: 6.4/10. Assessed: October 14, 2026. Methodology: 1.1.
| Area | Score | Main evidence |
|---|---|---|
| Competitive advantage | 7.0/10 | Documented NFL official-data exclusivity through the 2029 season and Football DataCo through 2028/29; technical integration and distribution create entry barriers. Leagues own the rights, however, and GENI must defend their renewal price. |
| Demand durability | 8.0/10 | Official data is important to live betting. Reported Betting growth was 32.9% in 2025 and 27.5% in Q2 2026; Q1 management cited revenue retention of 120–130%. Advertising and regulation reduce overall resilience. |
| Management execution | 7.0/10 | Documented outperformance of original 2024 and 2025 guidance; Q2 2026 delivered revenue of USD 195.5 million and EBITDA of USD 52.6 million versus guidance of USD 185 / 45 million. Legend returns and promised second-half cash remain unproven. |
| Business economics | 5.0/10 | Reported adjusted EBITDA margins of 20.4% in 2025 and 26.9% in Q2 2026. Against this, first-half operating cash flow was −USD 147.2 million and approximately −USD 188.0 million after ordinary investment and software; per-share value creation is not yet established. |
| Financial resilience | 5.0/10 | At June 30, 2026, cash was USD 155.1 million and nominal debt USD 825 million; the loan matures in April 2031 and covenants were met. Interest, ongoing principal payments, acquisition obligations and stock awards limit reserves if cash flow weakens. |
- Brief rationale: the result is the simple average (7.0 + 8.0 + 7.0 + 5.0 + 5.0) / 5 = 6.4. Exclusive rights, the need for data and repeated delivery of operating guidance support business strength. Debt and unproven sustainable FCF per share prevent placing the entire business in the 7–8 band.
- Main weakness: EBITDA growth does not yet demonstrate cash available to shareholders after interest, investment, deferred payments and dilution.
- Assessment confidence: medium — statements, contracts and multiple periods support all five areas, but Legend integration continues and complete coverage of newer evidence and filings is not confirmed.
- Revision condition: an increase requires demonstrated sustainable after-interest FCF and growing FCF per diluted share alongside debt reduction in 2027. Losing major rights, deteriorating renewal economics, two quarters of organic Betting growth below 15%, or missed cash conversion without a credible explanation would support a reduction.
Main sources: NFL, June 11, 2025 announcement and Football DataCo, August 5, 2024 for rights scope and duration; FY2025, released March 4, 2026 for 2025 results; Q2 / first-half 2026, released August 6, 2026 and SEC interim report as of June 30, 2026, especially Notes 9–12 for economics and financing. Retention and second-half cash-flow statements are management claims in the Q1 transcript, May 7, 2026 and Q2 transcript, August 6, 2026. The score is unchanged at the October 14 review versus the October 10 assessment: available evidence did not establish a new fact changing any of the five areas. Methodology 1.1 changes notation to one decimal place, not definitions or weights; component values are unchanged without new evidence. Share-price movements and ownership do not enter the score.
Growth Drivers
Q3 update
The main growth drivers remain greater monetization of official rights, higher customer spend, more products on the same infrastructure, Legend media monetization and prediction-market partnerships. Q3 Betting growth and faster-than-planned Legend integration support them; recurring cash after rights costs, interest, acquisition payments and dilution remains the test.
| Driver | Mechanism/evidence | Required continuation |
|---|---|---|
| Official data/contracted access | Major exclusive rights; approximately 500 sportsbook brands per management | Monetization outgrows rights costs; renewals retain economics |
| Existing-customer spending | Q1 NRR 120–130%; Q2 Betting +28% | Products, repricing and in-play support durable mature-market growth |
| Shared infrastructure use | GeniusIQ across data, officiating, analytics, broadcast, ads | Additional profit without matching cost/investment growth |
| Legend/ads | Owned media and acquisition; initial claimed synergies | Traffic quality, repeat budgets and cash justify price |
| Prediction markets | Q2 category revenue; direct Kalshi/Polymarket deals after quarter-end | Paid data/marketing expands within permitted rights/regulation |
Q1 · Q2. NRR/synergies are management claims; last column contains analytical tests. The hypothesis: more products/buyers increase one sports-data relationship's value while infrastructure stays partly shared.
Prediction markets add optional growth. Kalshi/Polymarket enable data, integrity and acquisition uses. NFL is excluded from 2026 guidance for this category; deals do not cover all leagues/uses automatically. Q2. Prediction.com launched September 17 for contract discovery/comparison; financial impact unquantified.
Economics & Financial Profile
| Metric | FY 2024 | FY 2025 | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|---|---|
| Revenue | 510.9 | 669.5 | 188.0 | 195.5 | 269.9 |
| Year-on-year revenue growth | 24.5% | 31.0% | 30.5% | 64.7% | 62.3% |
| Adjusted EBITDA | 85.7 | 136.2 | 24.0 | 52.6 | 87.1 |
| Adjusted EBITDA margin | 16.8% | 20.4% | 12.8% | 26.9% | 32.3% |
| GAAP operating income or loss | — | — | — | — | 10.4 |
| GAAP net income or loss | −63.0 | −111.6 | −55.5 | −76.7 | −15.7 |
Q3 delivered the first strong cash-flow evidence: operating cash flow was $79.4 million and reported FCF was $53.6 million, 61.5% of adjusted EBITDA. Nine-month operating cash flow remained −$67.9 million and FCF −$136.2 million, so Q4 and 2027 must confirm sustainability. Full-year 2026 guidance was raised to revenue of $1,015–1,035 million and adjusted EBITDA of $287–297 million. At September 30, cash was $206.5 million, debt book value $787.4 million, contingent consideration $202.5 million and ordinary shares 267.9 million. Management prioritizes debt repayment over buybacks and targets roughly 2× year-end net leverage.
Sources: Q3 results and Q3 call. Adjusted EBITDA is non-GAAP and is not net income or free cash flow.
Key KPIs
Q3 update
Key current indicators are 33.4% Betting growth, 32.3% adjusted EBITDA margin, $10.4 million operating income and $53.6 million FCF. The next test is Q4 and 2027 cash conversion, together with diluted shares, debt and rights-renewal economics.
| KPI | Latest figure/guidance | Watch |
|---|---|---|
| Betting growth | Q2 28% YoY | Organic pace/margins after rights |
| NRR | Q1 120–130%, management | Same-base spending |
| Media growth | Q2 reported 193%, includes Legend | Separate acquired/organic growth/synergies |
| Adjusted EBITDA margin | Q2 26.9%, FY midpoint 28.6% | Leverage plus cash |
| H2 cash flow | 145 before interest, 115 after, 105 after principal | Actual bridge, transactions/seasonality |
| Cash/nominal debt | June 30 155.1 / 825; guided year-end cash ~260 | Liquidity and later deleveraging |
| Economic shares | June 30 267.6 common + 19.5 NFL warrants, before employee awards | Dilution/FCF per share |
Organic versus acquisition: Legend from May 1 means group 65% and Media 193% cannot be extrapolated organically. CFO says both media businesses organically exceed 20%, but discloses no separate revenue; standalone Legend returns/synergies are not fully verifiable. Q2.
NRR/organic media are management figures; H2 cash/year-end balance are guidance. Q1 · Q2 · Balance sheet/outlook.
Management & Capital Allocation
Mark Locke, co-founder and CEO, has more than 20 years of industry experience. Bryan Castellani, CFO since October 2025, previously held senior finance roles at ESPN, Disney and Warner Music Group.
| Promise check | Initial plan | Actual result | Interpretation |
|---|---|---|---|
| FY 2024 revenue / adjusted EBITDA | 480 / 75 | 510.9 / 85.7 | 6.4% / 14.3% above the initial plan. |
| FY 2025 revenue / adjusted EBITDA | 620 / 125 | 669.5 / 136.2 | 8.0% / 9.0% above the initial plan. |
| Q2 2026 revenue / adjusted EBITDA | 185 / 45 | 195.5 / 52.6 | 5.7% / 16.9% above plan. |
| Q2 2026 cash | 140–150 | 155.1 | Above the range stated on the Q1 call. |
| Q3 2026 revenue / adjusted EBITDA | 260 / 85 | 269.9 / 87.1 | 3.8% / 2.5% above plan; FY guidance raised. |
| H2 2026 FCF / year-end cash | Above 100 / about 260 | Q3 FCF 53.6 / cash 206.5 | First half of the test met; Q4 and 2027 determine sustainability. |
ChatGPT's analytical conclusion: operating planning has a good documented record and Q3 added the first positive operating profit and strong FCF. Evidence on capital allocation after the large acquisition and normalized full-year FCF remains weaker. Debt repayment and a specific Q4 cash-flow expectation are positive; the lack of a separate Legend bridge and quantified synergies remains a limitation.
Risks / Bear Case
Updated bear case
The main risks remain rights-renewal costs, weaker monetization, Legend advertising returns, regulation, leverage, contingent consideration and dilution. The bear model uses $1.2 billion of 2029 revenue, a 23% EBITDA margin, 7× EV/EBITDA, $650 million of net debt and remaining cash consideration, and 340 million diluted shares.
| Risk | Stock mechanism | Watch |
|---|---|---|
| Rights cost/renewal | Higher prices/license changes weaken cash conversion | NFL/DataCo terms, Betting margins, rights payments |
| Legend traffic | Small synergies, AI/search traffic loss, lower ad budgets | Organic Media, repeat campaigns, traffic sources/conversion |
| Debt/payments | Interest/earn-out consume cash; more funding | After-interest FCF, net debt, liquidity, earn-out settlement |
| Dilution | EBITDA and shares grow together | NFL warrants, RSUs/PSUs, grants/acquisition shares |
| Prediction markets | Regulatory limits, weak paid data need, temporary ads; direct liquidity provision adds trading losses | Paid renewals, rights scope, revenue share |
| Data integrity/operations | Outages/errors damage trust | Uptime, incidents, claims/protection costs |
My interpretation: broader than a pure US sportsbook bet. European taxes/rules affect customer ads; non-US revenue adds FX. CBF technology cooperation differs economically from direct Brazilian betting revenue. Brazil · Q1 discussion.
- Brazil: September 28 guidance reaffirmed with management expecting immaterial GENI/Legend impact from new restrictions. This does not remove future regulatory risk. Company statement.
Bear mechanism: cash lags EBITDA, Legend fails to cover higher costs and debt does not fall enough. Lower multiples and share-paid contingencies weaken per-share returns despite business growth. 20-F · Legend acquisition · Q1/Q2 transcripts.
Valuation
ChatGPT produces the calculations and valuation scenarios. Share-price inputs are dated to the analysis; they are not continuously updated market data.
Different outcomes. Different values.
5.92 USD · November 5, 2026 · close
Price attractiveness — November 6, 2026
6.3/10 at $5.92, the November 5 NYSE close. Three-year horizon to November 6, 2029. The unchanged base case uses a terminal price of $11.23, zero dividends and a total return of +89.7%. The bear case uses $3.77, zero dividends and −36.3%. The lower entry price and Q3 evidence raise the score from 6.0 to 6.3, while debt, contingent payments, dilution and unproven full-year cash conversion keep confidence low. A strong-execution sensitivity of $22.29 is retained but is not used for the score.
Current price reference: USD 6.53, October 13, 2026 closing price, NYSE: GENI, ordinary share; checked October 14, 2026 in quote history. The 267.6 million ordinary shares reported at June 30, 2026 imply basic capitalization of approximately USD 1.75 billion. At that date there were also 19.5 million NFL warrants with an almost-zero exercise price, of which 14.5 million were vested and 5 million were subject to future vesting; a conservative total is 287.1 million economic shares before employee compensation. Voting B shares are not added again. This reprices June's share count rather than establishes an exact current fully diluted count. SEC Notes 11–12. The traded security's designation as an ordinary share is confirmed by SEC, FY2025 securities description.
Indicative bridge including all NFL warrants at USD 6.53: USD 1.87 billion equity value + USD 825 million nominal debt − USD 155.1 million cash = USD 2.54 billion EV, before other deferred payments. Including USD 214.1 million reported contingent and USD 13.2 million deferred consideration produces an expanded value of approximately USD 2.77 billion, or 9.6× the USD 290 million midpoint of 2026 EBITDA guidance. Balance-sheet inputs are as of June 30, 2026. This conservatively treats deferred consideration as cash; settlement in shares belongs in dilution instead. Balance sheet and guidance, released August 6, 2026 · SEC Notes 8–9.
This bridge is not complete current fully diluted capitalization. Employee awards, future grants and earn-out settlement remain sensitivities. Operating leases are not added separately to this EBITDA multiple because US GAAP rent remains an operating expense; this does not use pre-rent EBITDA. My interpretation: a low adjusted-earnings multiple can indicate opportunity or distrust in cash conversion.
The company's target is not the base case: when announcing Legend, management set 2028 revenue of USD 1.6 billion, an approximately 35% EBITDA margin and at least 60% FCF conversion; calls clarify that conversion is before interest. This is a management ambition. During the October 5, 2026 check, a public aggregator reported revenue estimates around USD 1.02 billion for 2026 and USD 1.30 billion for 2027, but separate FCF estimates and full consensus were not verified. These estimates were not rechecked on October 14 and are not a new assessment input. Company targets · Aggregated estimates.
Price Attractiveness
Price attractiveness: 6.0/10 at USD 6.53. Security: GENI, ordinary share, NYSE. Quote date: October 13, 2026, closing price (16:00 EDT). Assessed: October 14, 2026. Horizon: October 14, 2026 through October 14, 2029 (three years). Methodology: 1.1. Quote source: StockAnalysis price history.
The following is our 2029 sensitivity model, rather than an analyst target or company guidance. Annual 2029 performance approximates valuation on October 14, 2029 at the end of the same three-year horizon in both cases. The base assumes slower realization of management's ambitions; the bear case captures weaker growth, margins, more expensive financing and greater dilution. Share value = (revenue × EBITDA margin × EV/EBITDA − net debt and remaining cash consideration) / modeled diluted shares. Returns are in USD before taxes, fees and currency effects. Monetary table values are in USD millions except per-share amounts.
| Item | Base case | Bear case |
|---|---|---|
| Business assumptions | Further rights/Legend monetization; slower delivery of management ambitions | Weaker monetization, pressure on rights costs and poorer Legend returns |
| 2029 revenue | 1,500 | 1,200 |
| Annual growth from 2026 guidance midpoint | 13.9% | 5.7% |
| Adjusted EBITDA margin / EBITDA | 30% / 450 | 23% / 276 |
| FCF conversion before interest | 60% | 45% |
| Annual cash interest | 35 | 50 |
| FCF after interest, before principal and earn-out | 235 | 74 |
| Future valuation — terminal EV/EBITDA | 9× | 7× |
| Net debt and remaining cash consideration | 400 | 650 |
| Modeled diluted shares, millions | 325 | 340 |
| Price in three years | USD 11.23 | USD 3.77 |
| Three-year dividends — our assumption | USD 0 | USD 0 |
| Total three-year return from USD 6.53 | +72.0% | −42.3% |
| Approximate annual return | +19.8% | −16.7% |
| Present equivalent of terminal price at a 12% discount | USD 8.0 | USD 2.7 |
Additional strong execution: the original optimistic sensitivity is retained: USD 1,850 million revenue (22.2% annual growth), 35% margin, approximately USD 648 million EBITDA, 65% FCF conversion, USD 25 million interest and approximately USD 396 million after-interest FCF. At 11× EV/EBITDA, USD 100 million net cash obligations and 315 million shares, the three-year price is approximately USD 22.29, dividends USD 0, total return +241.4% and annual return +50.6%; the present equivalent at a 12% discount is USD 15.9. This case does not determine the attractiveness score.
Model assumptions and limitations: debt, deferred payments, interest, multiples and share counts are our scenario assumptions. FCF conversion assumes cash taxes and ordinary investment, including software, have been paid. Cash earn-out settlement is already reflected in cash obligations; share settlement belongs in share count, rather than both simultaneously. Greater bear-case dilution assumes more equity funding. Lower strong-case interest and debt require actual cash flow after deferred payments. The model does not yet have a complete annual settlement schedule.
Discounted terminal price is neither a full DCF nor precisely measured intrinsic value. It does not separately distribute interim FCF, which primarily pays consideration and reduces debt. No scenario probabilities are assigned. A base present equivalent around USD 8 suggests room versus USD 6.53, but unverified cash conversion limits valuation confidence. Each additional USD 100 million of net cash obligations reduces base value by approximately USD 0.31 per share; each 1× multiple changes it by approximately USD 1.38.
- Brief rationale: at USD 6.53, the base case offers approximately +72.0% over three years, while the bear case loses approximately 42.3%. Risk/reward therefore remains in the upper part of the roughly fair-price band. Versus the USD 6.65 October 9 close, the price fell 1.8%; this move under unchanged scenario assumptions does not justify changing attractiveness from 6.0/10. Decimal notation under methodology 1.1 does not mean a new numerical reassessment.
- Main weakness: terminal net debt, cash consideration and dilution depend on unproven cash generation; weaker FCF can worsen all three simultaneously.
- Assessment confidence: low — the quote and starting balance sheet are verified and both cases are defensible, but future cash conversion, earn-out settlement and shares remain working assumptions without a complete annual cash schedule.
- Revision condition: a lower price with assumptions intact, or demonstrated FCF per share and debt reduction, would raise the assessment. A higher price without business improvement, a missed second-half cash-flow outlook or debt/dilution above the base case would reduce it.
Return calculation: (price in three years + cumulative dividends) / 6.53 − 1, using unrounded modeled prices and dividends without reinvestment. Scenarios and dividends are our assumptions, rather than a company promise. Operating and balance-sheet basis: Q2 / first-half 2026 results, released August 6, 2026 and SEC interim report as of June 30, 2026; management reaffirmed 2026 guidance on September 28, 2026. Price basis: October 13, 2026 closing quote, checked October 14. Other main sources and periods are listed with the Business strength.
What Would Change the Assessment?
Updated conditions
A stronger view requires repeatable FCF after interest, growth in FCF per diluted share, debt reduction and evidence that Legend earns an adequate return. A weaker view would follow loss of major rights, worse renewal economics, two quarters of Betting organic growth below 15%, or renewed cash-conversion failure without a credible explanation.
My review signals, not guidance; normalize seasonality/transactions:
- Betting organic growth below 15% for two consecutive quarters.
- Material H2 cash-flow miss without documented timing explanation.
- Deleveraging stalls during 2027.
- Economic shares grow above 5% annually without matching FCF-per-share growth.
- Major rights lost or renewed at permanently damaging prices.
Confirmation: repeat organic growth, ordinary positive after-interest FCF, lower debt and new-product monetization. Damage: weaker growth, expensive rights, unstable Legend traffic and dilution together. Price declines or one weak seasonal quarter are not automatic breaks.
Current View
Current assessment — November 6, 2026
Q3 materially improved the operating evidence. Company strength rose from 6.4 to 6.6/10. At the $5.92 close, price attractiveness rose from 6.0 to 6.3/10. The thesis remains conditional because nine-month FCF was negative and debt, contingent consideration and dilution remain material.
Operationally supported thesis, medium confidence. Exclusive relationships, Betting growth and guidance delivery support the long-term story; Business strength remains 6.4/10 under methodology 1.1. At the USD 6.53 October 13, 2026 closing price, attractiveness is 6.0/10: the base three-year case offers approximately +72.0%, the bear case −42.3%. Valuation remains a working estimate with low confidence: after-interest cash, Legend returns and dilution will be decisive. The October 14 review did not establish a new operating fact requiring these conclusions to change; coverage is partial.
- Q3 plan: approximately USD 260 million revenue and USD 85 million adjusted EBITDA. The exact release date is not yet confirmed by a primary announcement; calendars estimate November 3, while management allowed for a later date on the call. Q2 outlook · Transcript.
The next content revision is appropriate after Q3 results or a change in rights, financing or guidance. Milestones and tasks provide a checklist for the next review.
Thesis History / Updates
| Date | Event | Thesis impact |
|---|---|---|
| Oct. 3–4, 2026 | Analytical framework defined around sports infrastructure, management, geography and rights durability. | Three-plus-year horizon; focus on business quality and per-share returns. |
| Oct. 5, 2026 | Thesis assembled from Q1 and Q2 results, transcripts and contracts; 2029 scenarios added. | Growth supported; cash conversion and Legend returns conditional. |
| Oct. 6, 2026 | Converted to the standard company-page structure. | Concise opening and KPI summary added. |
| Oct. 9, 2026 | Methodology 1.0 review and first dual rating. | Operating conclusion retained; valuation recalculated. |
| Oct. 10, 2026 | Closing price updated to $6.65. | Both scores unchanged. |
| Oct. 14, 2026 | Methodology 1.1 and $6.53 reference price. | Scores unchanged; one-decimal format adopted. |
| Oct. 21, 2026 | Methodology 1.2 and NFL Gametime on X evidence. | Product evidence supported the thesis but did not change scores. |
| Oct. 28, 2026 | Q3 date confirmed and price updated to $6.32. | Company strength unchanged; price score increased 0.1. |
| Nov. 4, 2026 | AFA/SAOT partnership update and $6.80 reference price. | Company strength unchanged; price score fell from 6.1 to 6.0. |
| Nov. 6, 2026 | Q3 results, public call transcript and $5.92 close incorporated. | Company strength rose 6.4→6.6; price attractiveness 6.0→6.3. |
Rating history
| Assessment date | Methodology | Company strength | Price attractiveness | Price reference | Reason |
|---|---|---|---|---|---|
| Oct. 9, 2026 | 1.0 | 6.4/10 | 6/10 | $6.63, Oct. 8 close | First methodology-aligned assessment. |
| Oct. 10, 2026 | 1.0 | 6.4/10 | 6/10 | $6.65, Oct. 9 close | No new business evidence; minor price move. |
| Oct. 14, 2026 | 1.1 | 6.4/10 | 6.0/10 | $6.53, Oct. 13 close | Business evidence unchanged; price move did not change the conclusion. |
| Oct. 21, 2026 | 1.2 | 6.4/10 | 6.0/10 | $6.68, Oct. 20 close | NFL distribution evidence lacked disclosed economics. |
| Oct. 28, 2026 | 1.2 | 6.4/10 | 6.1/10 | $6.32, Oct. 27 close | Lower price improved scenario asymmetry. |
| Nov. 4, 2026 | 1.2 | 6.4/10 | 6.0/10 | $6.80, Nov. 3 close | AFA/SAOT did not change strength; higher price reduced attractiveness. |
| Nov. 6, 2026 | 1.2 | 6.6/10 | 6.3/10 | $5.92, Nov. 5 close | Q3 beat plan, delivered positive operating income and $53.6m FCF; lower price improved both scenario returns. |
Earlier pages did not contain both scores and are not backfilled. Historical methodology 1.0 records remain immutable.
Was this analysis useful to you?